Agencies Streamline N95 Respirator Regulation to Enhance Supplies
The Food and Drug Administration today issued a final order exempting manufacturers from FDA premarket notification requirements for certain N95 respirators, disposable devices used to protect patients and health care providers from infection. Under a new memorandum of understanding between the FDA and National Institute for Occupational Safety and Health, organizations seeking to market N95 respirators that do not exceed certain criteria need only NIOSH certification. The final order and MOU, effective tomorrow, are intended to streamline regulatory requirements to help ensure adequate supply of the devices during public health emergencies.
Related News Articles
Headline
The Utah measles outbreak has increased to 583 cases, the state’s Department of Health and Human Services reported April 7. Of those, 386 cases have been…
Headline
Cases in the Utah measles outbreak have increased to 559, the state’s Department of Health and Human Services reported March 31. The agency said 362 cases have…
Headline
The AHA Feb. 18 responded to a request for information from Reps. Neal Dunn, R-Fla., and Lori Trahan, D-Mass., on the potential reauthorization of the Pandemic…
Headline
The measles outbreak in South Carolina has increased to 876 cases, the state’s Department of Public Health reported Feb. 3. Last week, the South Carolina…
Headline
Two AHA guides offer strategies for hospitals and health systems in preparing for public health emergencies and disasters and managing cybersecurity incidents…
Headline
The National Emerging Special Pathogens Training and Education Center announced Oct. 15 that it will award $37.5 million in grants to 75 hospitals seeking to…